Compound ID | 64
AP138 (Plectasin)
Class: Antimicrobial peptide
| Spectrum of activity: | Gram-positive |
| Details of activity: | MRSA (methicillin resistant Staphylococcus aureus) implant infections |
| Propensity to select resistant mutants: | Yes |
| Institute where first reported: | Adenium Biotech, Denmark |
| Year first mentioned: | 2004 |
| Highest developmental phase: | Preclinical |
| Development status: | Inactive |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.